Skip to main content

Table 2 Anti-HEV seropositive rates according to age groups and gender

From: Seroprevalence of anti-hepatitis E virus (HEV) in a Korean population: comparison of two commercial anti-HEV assays

 

Number tested

Seropositivities for :

Wantai % (95% CI)

P-value

Genelabs % (95% CI)

P-value

Age group, years

  

0.011

 

0.029

20-29

24

12.5 (0–25.5)

 

8.3 (0–19.3)

 

30-39

34

11.8 (0.8-22.8)

 

11.8 (0.8-22.8)

 

40-49

41

19.5 (0–31.5)

 

9.8 (0.8-18.8)

 

50-59

22

31.8 (12.8-50.8)

 

9.1 (0–21.1)

 

> 59

26

46.1 (27.1-65.1)

 

34.6 (16.6-52.6)

 

Gender

  

0.089

 

0.201

male

72

29.1 (19.1-39.1)

 

18.1 (9.1-27.1)

 

female

75

17.3 (9.3-25.3)

 

11.7 (4.7-18.7)

 

Total

147

23.1 (16.1-30.1)

 

14.3 (8.3-20.3)

 
  1. CI, confidence interval.
  2. P values by chi-square test.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us